Completed PHASE3 INTERVENTIONAL 1-arm NCT01246791

Pharmacokinetics of NPC-01 After Single Oral Administration in Healthy Female Volunteers

A Single Dose Pharmacokinetics Study of NPC-01 (1mg Norethisterone and 0.02mg Ethynyl Estradiol) in Healthy Female Volunteers

Sponsor: Nobelpharma

Conditions Healthy

Interventions NPC-01

Updated 9 times since 2017 Last updated: Jun 3, 2025 Started: Nov 30, 2010 Primary completion: May 31, 2011 Completion: May 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Healthy and is currently completed. Nobelpharma leads this study, which shows 9 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Jan 2026 — Present [monthly]

Completed PHASE3
Jul 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Jul 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2023 — Jul 2024 [monthly]

Completed PHASE3

▶ Show 4 earlier versions

Dec 2022 — Jan 2023 [monthly]

Completed PHASE3
Jan 2021 — Dec 2022 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Nov 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Nobelpharma

Data source: Nobelpharma

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.